RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial

NCT03067493 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Primary Liver Cancer
Radiofrequency Ablation
Immunotherapy
Hepatectomy

Interventions

BIOLOGICAL: Neo-MASCT

Sponsor

Sun Yat-sen University

Collaborators

[object Object]
[object Object]